CR Sanjiu announces 2024 equity distribution plan implementation
China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) announced the implementation of its 2024 equity distribution plan, approved at the annual shareholder meeting on April 17, 2025. Shareholders will receive a cash dividend of CNY 3.20 (tax included) per 10 shares. Additionally, the company will transfer 3 shares for every 10 shares from capital reserve. The equity distribution will be based on the total share capital on the record date, June 5, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
News Alerts
Get instant email alerts when China Resources Sanjiu Medical & Pharmaceutical publishes news
Free account required • Unsubscribe anytime